biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Day

April 28, 2022
PCR|ONE
28
Apr

Scope Fluidics S.A. completes certification clinical trials for its SARS-CoV-2 panel and commences certification clinical trials for its MRSA/MSSA panel

28.04.2022
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home